EP3250610
FcRn-mótefni og aðferðir til notkunar á þeim
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
29.1.2016EP published:
9.8.2023EP application number:
16744204.5
EP translation filed:
9.10.2023Grant published:
15.11.2023EPO information:
European Patent Register
Max expiry date:
28.1.2036Expiry date:
28.1.2027Next due date:
31.1.2027
Title in English:
FCRN ANTIBODIES AND METHODS OF USE THEREOFLanguage of the patent:
English
Timeline
Today
29.1.2016EP application
9.8.2023EP Publication
9.10.2023Translation submitted
15.11.2023Registration published
28.1.2027Expires
Owner
Name:
Momenta Pharmaceuticals, Inc.Address:
1125 Trenton-Harbourton Road, Titusville, NJ 08560, US
Inventor
Name:
KEHRY, MarilynAddress:
San Diego, CA 92131, US
Name:
KING, David, J.Address:
Encinitas, CA 92024, US
Name:
LING, Leona, E.Address:
Winchester, MA 01890, US
Name:
MEADOR, James IIIAddress:
Framingham, MA 01702, US
Name:
ROY, SucharitaAddress:
Acton, MA 01720, US
Name:
MANNING, AnthonyAddress:
Cambridge, MA 02139, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201562110071 PDate:
30.1.2015Country:
US
Number:
201562258082 PDate:
20.11.2015Country:
US
Classification
Categories:
C07K 16/28, G01N 33/68, A61P 35/00, A61P 37/00
Annual fees
Number
Paid
Expires
Payer
Number: 9
Paid: 18.12.2023
Expires: 28.1.2025
Payer: Árnason Faktor ehf.
Number: 10
Paid: 13.12.2024
Expires: 28.1.2026
Payer: Árnason Faktor ehf.
Number: 11
Paid: 20.1.2026
Expires: 28.1.2027
Payer: Árnason Faktor ehf.